SOLENO THERAPEUTICS INC - SLNO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G Avoro Capital Advisors LLC 5.4% 2,900,000 View
Feb 17, 2026 SCHEDULE 13G Behzad Aghazadeh 5.4% 2,900,000 View
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 13.4% 7,178,354 View
Feb 10, 2026 SCHEDULE 13G Wellington Management Group LLP 6.2% 3,322,799 View
Feb 10, 2026 SCHEDULE 13G Wellington Group Holdings LLP 6.2% 3,322,799 View
Feb 10, 2026 SCHEDULE 13G Wellington Investment Advisors Holdings LLP 6.2% 3,322,799 View
Feb 10, 2026 SCHEDULE 13G Wellington Management Company LLP 6.0% 3,322,799 View
Nov 14, 2025 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 11.4% 6,056,339 View
Nov 14, 2025 SCHEDULE 13G/A Vivo Opportunity Fund Holdings, L.P. 4.2% 2,251,160 View
Nov 14, 2025 SCHEDULE 13G/A Vivo Opportunity, LLC 4.2% 2,251,160 View
Nov 14, 2025 SCHEDULE 13G/A Vivo Opportunity Cayman Fund, L.P. 0.1% 27,043 View
Nov 14, 2025 SCHEDULE 13G/A Vivo Opportunity Cayman, LLC 0.1% 27,043 View
Nov 13, 2025 SCHEDULE 13G/A Adage Capital Management, L.P. 2.64% 1,401,576 View
Nov 13, 2025 SCHEDULE 13G/A Robert Atchinson 2.64% 1,401,576 View
Nov 13, 2025 SCHEDULE 13G/A Phillip Gross 2.64% 1,401,576 View
Oct 31, 2025 SCHEDULE 13G The Vanguard Group 5.28% 2,807,149 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.